USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Targeted Sequencing of Tumor Mutations is on the Horizon
29-Jun-2012
North America
Market Research
NB1D-01-00-00-00
HC02229-NA-MR_07963
This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on this analysis, revenue forecasts and growth rates are projected for each segment of the market. This study also provides cancer epidemiology trends, voice-of-customer research on oncologists, and the challenges and strategies for cancer biomarker validation.
Research Service
- Executive Summary
- Market Overview
Total U.S. Cancer Biomarker Testing Segment
- Industry Trends
- External Challenges: Drivers and Restraints
- Forecasts and Trends
- Market Share and Competitive Analysis
- Product Analysis
- Epidemiology
- Voice-of-Customer Research
- Cancer Biomarker Validation Challenges and Strategies
Molecular Cancer Biomarker Testing Segment Breakdown
- Forecast and Trends
Traditional Cancer Biomarker Testing Segment Breakdown
- Forecasts and Trends
The Last Word
- Conclusions and Implications
Appendix
- Appendix
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Author | Winny Tan |
| Industries | Healthcare |
| WIP Number | NB1D-01-00-00-00 |
| Is Prebook | No |
Analysis of the U.S. Cancer Biomarker Testing Market
$4,950.00
Special Price $3,712.50 save 25 %